Online Therapy for Gynecologic Cancer
(eSense-Cancer Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are in active treatment for cancer, you would not be eligible to participate.
What data supports the effectiveness of the treatment eSense-Cancer CBT for gynecologic cancer?
Research on similar online cognitive-behavioral therapy (CBT) programs for breast cancer patients shows that these interventions can reduce distress and improve quality of life. For example, the 'Finding My Way' study demonstrated that internet-based CBT can help individuals cope better with cancer-related distress.12345
Is online therapy safe for people with gynecologic cancer?
Research on internet-based cognitive behavioral therapy (iCBT) for breast cancer survivors shows it is generally safe and can help with symptoms like anxiety and depression. While this research is not specific to gynecologic cancer, it suggests that online therapy is safe for people with cancer.678910
How is the eSense-Cancer online therapy treatment different from other treatments for gynecologic cancer?
The eSense-Cancer online therapy is unique because it offers cognitive behavioral therapy (CBT) and mindfulness-based therapy (MBT) through an online platform, making it easily accessible and allowing patients to receive psychological support from the comfort of their homes. This approach is particularly beneficial for addressing emotional and psychosexual distress, providing anonymity and convenience compared to traditional in-person therapy sessions.1112131415
What is the purpose of this trial?
Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.
Research Team
Kyle Stephenson, PhD, RPsych
Principal Investigator
Xavier University of Louisiana.
Lori A Brotto, PhD, RPsych
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for individuals with a history of any gynecologic cancer who are experiencing sexual health concerns. Participants must be fluent in English, able to commit to an 8-16 week program, have reliable internet access, and be comfortable using online platforms.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and undergo a 4-week waiting period before a second baseline assessment
Treatment
Participants are randomized to one of four arms and complete 8 modules of CBT or MBT with or without navigator support
Post-Treatment Assessment
Participants complete post-treatment questionnaires to assess various feasibility dimensions and clinical outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- eSense-Cancer CBT
- eSense-Cancer MBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Xavier University of Louisiana.
Collaborator